Drug Profile
VN 8522
Latest Information Update: 08 May 2008
Price :
$50
*
At a glance
- Originator Vita
- Class
- Mechanism of Action 5-HT1A serotonin receptor agonists; Serotonin uptake inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Major depressive disorder
Most Recent Events
- 03 Sep 2004 Grupo Vita has been acquired by Procter & Gamble
- 03 Sep 2004 Grupo Vita is now called Vita
- 29 Oct 2002 Preclinical trials in Depression in Spain (unspecified route)